Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Wednesday, October 7, 2026

Back to today

From X

@convequity

Convequity on X

Why we exited $CRSP and kept $TEM AlphaFold solved the backend of the problem — predicting a protein’s 3D structure from its sequence. The harder frontend problem remains: knowing which protein or pathway is actually worth targeting. Most complex diseases are still poorly understood at the causal level. That distinction matters. The next real breakthroughs look more likely to come from AI-native groups that treat large-scale compute as the primary engine, in the same way OpenAI and Anthropic approached language before the ChatGPT moment. Public investors may only get clean access later via secondaries or IPOs. CRISPR sits on the earlier-generation side of that divide. Tempus is closer to the compute-and-data native side — building models while assembling a genuine clinical data moat. That is why one was exited and the other retained.
@evantindell

Evan Tindell on X

Finally got a chance to go through the $UMG earnings... Obviously, a disappointment on revenue growth and margins, which saw the stock drop like 20%. Subscription revenue was 6.7% organically, and the street was looking for >9%. So, a big miss. Still, I think things should improve. Apple, Spotify, Amazon, and YouTube music have all raised prices this year, and a portion of that will go to UMG. CFO Matt Ellis said on the call that these prices and "better market share to start the third quarter" make them "cautiously optimistic" (really sticking his neck out there!!) that growth will improve in H2 of 2026. Interestingly, Warner Music $WMG managed to grow revenue 12% in CC and adjusted OIBDA by 24%, so clearly this is a UMG-only problem, at least for this quarter. $UMG trades at 14x earnings on a NTM basis now... this seems pretty reasonable if not downright cheap for a company that has grown EBIT from EUR 1b in 2019 to around 2b today (11% organic EBITDA CAGR). We own this through Bollore, which currently has an NAV of just above 11 EUR by my calculation vs a last price of under 4 EUR. Notably, JPM thinks new AI tiers in Spotify and Apple Music will drive ARPU growth of 300 bps per year. Their price target was 48 EUR prior to the recent earnings release...

Investor Letters

All letters

Research Roundup Vol. LV

OpenAI’s enterprise privacy push and Synopsys’s Factory 2 royalty model anchor a technology roundup, alongside oil above $100 and Bitcoin’s…

SNPS $96B
Monte Independent Investment Research

New Position (ONON): Game is On

On Holding (ONON) is gaining sportswear share, expanding store space and launching soccer with Kylian Mbappé as investors debate U.S.

ONON $12B
Aurelion Research 3 clicks

Deep Dive: Intuit ($INTU)

Intuit’s $21.4 billion software franchise faces AI-driven pricing pressure in tax and accounting, even as QuickBooks and TurboTax retain…

INTU $82B
Rebound Capital 4 clicks
VEEV · long

Veeva Systems INC

Veeva Systems is a vertical software company valued as if its best growth years are behind it.

VEEV $48B
Value Investors Club

Canterra Minerals: Research Note

Canterra Minerals increased Lundberg indicated tonnage 55% to 26.1Mt, with 226.2Kt of contained copper equivalent, supporting a Buchans…

EQX $13B
Atrium Research - Equity Research 1 click

Kenorland Minerals: Research Flash

Franco-Nevada bought 10.0 million Kenorland shares, a 12.4% stake, for C$22.2 million in a secondary transaction that issued no new shares.

FNV $47B
Atrium Research - Equity Research 2 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 49 of 225

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

88 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.